Among emerging targets, metastasis-associated protein 2 (MTA2) is overexpressed in PDAC and promotes tumor progression partly by repressing PTEN transcription, thereby fueling PI3K/AKT hyperactivation [15,16]. The gene discussed is AKT1; the disease is neoplasm.